Neuropathy Science
Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective
This comprehensive study, available on PubMed Central, examines the potential of targeting endocannabinoid degradation enzyme inhibitors for the development of new antipsychotic medications. Schizophrenia and other psychotic disorders often lack effective treatments with minimal side effects, driving the need for innovative approaches. The endocannabinoid system, known for its role in Read more…